Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NCT05750030 - Atezolizumab + Bevacizumab + Fecal microbiota transplantation (FMT) & Hepatocellular Carcinoma (HCC) is a non-randomized clinical phase II treatment trial studying Atezolizumab + Bevacizumab + Fecal microbiota transplantation (FMT) in patients with Hepatocellular Carcinoma (HCC)
…